Overview
Last month, the Unified Patent Court (UPC) celebrated its one-year anniversary after it launched in 17 countries across Europe. During this time, it has significantly impacted many industries and fields, including medical devices, pharmaceuticals and various electronics. Decisions on key issues have undoubtedly contributed to the UPC’s growth, already establishing the new court as a popular venue for patent disputes.
In this article, Chuck Larsen, Aashish Kapadia and Charles de Raignac explore the significant decisions that are shaping the court’s direction, particularly in transatlantic disputes. Patent holders should be aware of these decisions and stay attuned of upcoming decisions that will continue to develop the UPC’s law and practice and shape its future usage.
Karen Gover contributed to the development of this article.
